Next Science Limited
ASX:NXS.AX
0.2 (AUD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.414 | 16.896 | 11.921 | 4.998 | 5.843 | 3.734 | 0 | 0.119 |
| Cost of Revenue
| 10.633 | 4.991 | 3.727 | 1.78 | 12.982 | 14.726 | 0.003 | 1.808 |
| Gross Profit
| 22.781 | 11.905 | 8.194 | 3.218 | -7.139 | -10.992 | -0.003 | -1.689 |
| Gross Profit Ratio
| 0.682 | 0.705 | 0.687 | 0.644 | -1.222 | -2.944 | 0 | -14.212 |
| Reseach & Development Expenses
| 8.571 | 7.929 | 5.967 | 8.649 | 2.492 | 1.664 | 0 | 0.694 |
| General & Administrative Expenses
| 5.61 | 5.385 | 4.106 | 3.144 | 8.447 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 20.165 | 10.31 | 7.395 | 5.648 | 0.65 | 0 | 0 | 0 |
| SG&A
| 38.355 | 22.289 | 15.027 | 12.771 | 8.406 | 5.922 | 0.046 | 1.954 |
| Other Expenses
| 0.099 | 0.072 | 0.265 | 0.544 | 0.074 | 0 | 0 | 0 |
| Operating Expenses
| 46.927 | 30.218 | 20.994 | 21.42 | 10.897 | 7.586 | 0.046 | 2.648 |
| Operating Income
| -24.145 | -18.313 | -12.8 | -18.203 | -18.036 | -18.578 | -0.049 | -4.337 |
| Operating Income Ratio
| -0.723 | -1.084 | -1.074 | -3.642 | -3.087 | -4.976 | 0 | -36.494 |
| Total Other Income Expenses Net
| -0.368 | 0.017 | 0.344 | 0.9 | -2.616 | 0.166 | -0.014 | 0.943 |
| Income Before Tax
| -24.513 | -18.296 | -12.457 | -17.303 | -20.652 | -18.412 | -0.063 | -3.394 |
| Income Before Tax Ratio
| -0.734 | -1.083 | -1.045 | -3.462 | -3.534 | -4.931 | 0 | -28.562 |
| Income Tax Expense
| 0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Net Income
| -24.513 | -18.296 | -12.457 | -17.303 | -20.652 | -18.412 | -0.063 | -3.394 |
| Net Income Ratio
| -0.734 | -1.083 | -1.045 | -3.462 | -3.534 | -4.931 | 0 | -28.562 |
| EPS
| -0.1 | -0.087 | -0.063 | -0.092 | -0.12 | -0.1 | -0 | -0.019 |
| EPS Diluted
| -0.1 | -0.087 | -0.063 | -0.092 | -0.12 | -0.1 | -0 | -0.019 |
| EBITDA
| -22.468 | -17.019 | -11.747 | -17.184 | -17.223 | -18.25 | -0.046 | -4.226 |
| EBITDA Ratio
| -0.672 | -1.007 | -0.985 | -3.438 | -2.947 | -4.888 | 0 | -35.557 |